Cell compositions derived from dedifferentiated reprogrammed cells
US9988604B2 · kind B2 · utility
0Cited by
33References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 2015 |
| Grant date | Jun 5, 2018 |
| Priority date | — |
| Expiry date | Apr 26, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2506/45
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are cell culture compositions, for example, pancreatic cell culture compositions, derived from dedifferentiated human reprogrammed pluripotent stem cells, such as induced pluripotent stem (iPS) cells, and methods for producing and using such cell culture compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.